Director, IPO-Ready SEC Reporting & Technical Accounting

Braveheart Bio

United States

On-site

USD 190,000 - 260,000

Full time

14 days+
Application generator

Stand out for this role — generate a tailored resume and cover letter in about a minute.

Get past ATS filters

Benefits offered by this job

Annual bonus
Equity
Comprehensive benefits

Job summary

Braveheart Bio in the United States seeks a Director of SEC Reporting and Technical Accounting to lead SEC reporting operations, internal controls, and related memos for a fast-moving biotechnology public company.

You will own 10-Qs/10-Ks, annual proxy, equity compensation, ASC 718, ASC 740, and manage external audits while building scalable finance infrastructure with cross-functional teams.

Qualifications

  • CPA required; public accounting background preferred.
  • Strong knowledge of US GAAP, SEC reporting, internal controls (SOX).
  • Technical accounting expertise including ASC 718 and ASC 740.
  • Experience managing Big 4 audits.
  • IPO experience preferred.
  • Ability to build finance infrastructure in biotech IPO.
  • Excellent communication and cross-functional collaboration skills.

Responsibilities

  • Own the preparation and filing of 10-Qs/10-Ks and annual proxy in accordance with US GAAP and SEC requirements.
  • Develop and maintain SEC reporting policies, procedures, and internal controls.
  • Manage external audit relationships and lead audit readiness processes.
  • Own accounting for equity compensation (ASC 718), income tax (ASC 740), and other technical accounts.
  • Review new contracts for proper accounting treatment and coordinate with FP&A for budgeting.
  • Prepare or supervise external specialists in technical accounting memos.
  • Administer the Company’s equity plan(s) including onboarding, grants, modifications, and terminations.
  • Manage annual income tax requirements and liaise with external tax providers.
  • Assist in quarterly Disclosure Committee and Audit Committee communications.
  • Implement and optimize equity administration systems (E-TRADE/EEO).
  • Assist in hiring and developing a small, high-performing accounting and finance team.

Skills

SEC reporting
SOX controls
Public company finance
Cross-functional collaboration
Communication
IPO experience

Education

CPA

Tools

E-TRADE equity platform
SEC disclosure software

Job description

Braveheart Bio in the United States seeks a Director of SEC Reporting and Technical Accounting to lead SEC reporting operations, internal controls, and related memos for a fast-moving biotechnology public company.

You will own 10-Qs/10-Ks, annual proxy, equity compensation, ASC 718, ASC 740, and manage external audits while building scalable finance infrastructure with cross-functional teams.

Get your free, confidential resume review.
or drag and drop your file here.
Similar jobs

Similar jobs worth comparing

IPO-Ready Director, SEC Reporting & Technical Accounting
IPO-Ready Director, SEC Reporting & Technical Accounting

Brave • San Francisco (CA)

Hybrid
USD 200,000 - 240,000
Director of SEC Reporting and Technical Accounting
Director of SEC Reporting and Technical Accounting

Braveheart Bio • United States

On-site
USD 190,000 - 260,000
Annual bonus
Equity
Comprehensive benefits
Director of SEC Reporting and Technical Accounting
Director of SEC Reporting and Technical Accounting

Brave • San Francisco (CA)

Hybrid
USD 200,000 - 240,000
Director, SEC & Technical Accounting — CPA Required
Director, SEC & Technical Accounting — CPA Required

Oliver James Associates Ltd. • Town of Charlotte (NY)

On-site
USD 180,000 - 240,000
Director, SEC Reporting & SOX — Biotech (Equity Eligible)
Director, SEC Reporting & SOX — Biotech (Equity Eligible)

Erasca, Inc. • San Diego (CA)

On-site
USD 190,000 - 220,000
Annual bonus
Equity grant
Comprehensive benefits
+2
Senior Director of External Reporting & Technical Accounting
Senior Director of External Reporting & Technical Accounting

Inspire Medical Systems • Minneapolis (MN)

On-site
USD 192,000 - 275,000
Health insurance
401k with employer match
Tuition reimbursement
+1
Director, Technical Accounting & External Reporting — Biotech Growth
Director, Technical Accounting & External Reporting — Biotech Growth

Superluminal Medicines Inc. • Boston (MA)

On-site
USD 180,000 - 240,000
401(k) match
Equity
Unlimited PTO
+1
Director, SEC Reporting & Technical Accounting—IPO-Ready Leader
Director, SEC Reporting & Technical Accounting—IPO-Ready Leader

PlusAI • Santa Clara (CA)

On-site
USD 175,000 - 220,000
Catered free lunch
Unlimited snacks and beverages
401(k) plan
Technical Accounting & SEC Reporting Strategy Lead
Technical Accounting & SEC Reporting Strategy Lead

SHINE Technologies LLC • Janesville (WI)

On-site
USD 165,000 - 185,000
IPO-Ready Director of Technical Accounting & SEC Reporting
IPO-Ready Director of Technical Accounting & SEC Reporting

Swoop • United States

On-site
USD 165,000 - 210,000